The government has signed an agreement with Indian authorities for the purchase of millions of doses of the Covovax vaccine for the coronavirus disease (Covid-19).
Vaccine czar Carlito Galvez Jr. signed a term sheet last Saturday with the Serum Institute of India (SII) and Faberco Life Sciences Inc. to reserve 30 million doses of the vaccine developed by the United States-based Novavax and produced in India.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.